Literature DB >> 14508864

Palliative therapy for lung cancer.

Andrea Bezjak1.   

Abstract

Attention to palliation is imperative in the management of patients with lung cancer, given the burden of symptoms and the incurable nature of the illness in a large proportion of patients. Focus on symptom control and enhancing quality of life can and should coexist with active treatment of the cancer process and attempts at prolongation of life. This article reviews some of the methodological issues in assessing palliation, and presents the evidence for the role of various therapeutic modalities in palliation of thoracic symptoms, including external beam radiotherapy, brachytherapy, chemotherapy, photodynamic therapy, and vascular stents. Palliation of metastatic disease, particularly bone and brain metastases, is also reviewed. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 14508864     DOI: 10.1002/ssu.10031

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  4 in total

Review 1.  Palliative radiotherapy for bone metastases from lung cancer: Evidence-based medicine?

Authors:  Alysa Fairchild
Journal:  World J Clin Oncol       Date:  2014-12-10

2.  Metastasis to the occipitocervical junction: A case report and review of the literature.

Authors:  Risheng Xu; Daniel M Sciubba; Ziya L Gokaslan; Ali Bydon
Journal:  Surg Neurol Int       Date:  2010-05-31

Review 3.  An Update on the Quality of Life Measurements in Lung Cancer Patients Receiving Palliative Radiotherapy: A Literature Review.

Authors:  Dominic Chu; Jasmine Nguyen; Kaitlin Koo; Liang Zeng; Gillian Bedard; Henry Lam; Erin Wong; Marko Popovic; Edward Chow
Journal:  World J Oncol       Date:  2013-05-06

4.  Meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer.

Authors:  Jie-Tao Ma; Jia-He Zheng; Cheng-Bo Han; Qi-Yong Guo
Journal:  Cancer Sci       Date:  2014-08       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.